New drug duo aims to boost brain healing after stroke
NCT ID NCT07283159
Summary
This study is testing whether adding a drug made from human urine proteins (urinary kallidinogenase) to the standard clot-busting medicine (tenecteplase) helps people recover better from a stroke. It will involve 200 adults who have just had a stroke and received the standard clot-buster within 4.5 hours. Researchers will compare recovery and safety between those who get the extra drug and those who do not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Neurology, General Hospital of Northern Theater Command
RECRUITINGShenyang, 110016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.